Crumdale Partners Ranked #2 on “Soaring 76”
Crumdale Partners, a purveyor of diversified insurance solutions, was ranked #2 on the...
Read MoreMatthew Naylor: 2020 Finalist for Entrepreneur of the Year
EY Announces Matthew S. Naylor of Crumdale Partners as an Entrepreneur Of The Year® 2020 Greater...
Read MoreCOVID-19 Insights & Estimated Impact on Health Plans
These certainly are unprecedented times as individuals, companies and governments take steps to...
Read MoreEmployee Spotlight: Jason Lohman
Chief Operation Officer, Crumdale Partners’ Pharmacy Division (Transformation Rx) Jason Lohman has...
Read MoreHigh-Deductible Health Plans May Now Waive Cost Share for Coronavirus Tests
On March 11th, the Internal Revenue Service (IRS) announced that high-deductible health plans...
Read MoreWhat is Leveraged Trend?
Those in the stop loss market have heard the phrase “leveraged trend” when discussing renewal calculations with your stop loss carrier. While few understand how this works, all have seen its’ significant impact on your clients’...
Read MoreWhat’s My Appropriate Specific Stop Loss Level?
You’ve made the decision to convert your health insurance benefit plan from an insured arrangement to a self-funded arrangement. Under your insured arrangement your carrier offered you a pool point that you had little or no...
Read MoreEmployers Begin Taking Steps to Combat the Coronavirus
It is estimated over 75,000 people worldwide have been infected with the coronavirus, with death figures approaching 2800 people. The fear of this potentially deadly virus has employers beginning to take steps to protect their...
Read MoreFDA Approves First Medication for Treatment of Peanut Allergy
On January 31st, 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia to reduce...
Read MoreNew Year = New Medication Price Increases
Starting January 1st, over 550 medications increased their price a median 5% according to a report by 3 Axis Advisors. More price increases are expected over the next few weeks. Many drug manufactures have pledged to not...
Read MoreFDA Drafts Guidance for Importation of Medications
On December 17, 2019, The Food and Drug Administration (FDA) proposed guidance for the importation of medications from Canada. The goal of this proposal is to allow patients access to FDA approved medications from abroad at a...
Read MoreNew Proposed Rules would Significantly Increase Hospital/Insurer Price Transparency for Employers
The U.S. Department of Health and Human Services recently released two sets of regulations that would make health care costs publicly available. These regulations could significantly shake up the health care space making it...
Read MoreDrug Watch: Treatments for Peanut Allergies
The U.S. Food and Drug Administration (FDA) is expected to decide on two new peanut allergy therapies in the next 6 months. These emerging medications are expected shift how patients with this condition are treated. The American...
Read More